Licensing Targets
We continuously look to license or acquire new products and solutions aimed at addressing the essential needs of consumers, patients and health care partners, leveraging our North American sales force and infrastructure.
Canada
- Rheumatology/Auto-immune disease
- Specialty Oncology
- Pediatrics
- Allergy
- Dermatology
USA
- Rheumatology/Auto-immune disease
- Specialty Oncology
Our Divisions
We operate through two segments: Medexus Pharma Canada and Medexus Pharma USA. We have excellent coverage of rheumatologists in the USA and Canada, plus coverage of pediatrics, allergy and primary care in Canada.
View Divisions
Product Portfolio
Our highly diversified product portfolio and growing pipeline features several leading products such as Rasuvo, Metoject, Rupall, Treosulfan, and Gleolan. The majority of our portfolio is in growth phase.
View Product Portfolio